ICU Medical Inc. (ICUI) - Long-Term Liabilities to Capital

The production of infusion systems is characterized by complete non-cyclicality and a lack of seasonality, as confirmed by the current price chart on the GURU.Markets platform, where the metric stands at 0.62. ICU Medical, Inc. (ICUI) relies on the manufacturing of critical care products within a mature market stage. However, potential quality-related lawsuits and rising polymer costs could negatively impact the company's final financial results.

This indicator measures the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial leverage stability by excluding short-term fluctuations. An analysis of the long-term debt-to-equity ratio confirms the investment stability of ICU Medical, Inc. (ICUI), as long-term patents and strict FDA compliance ensure a predictable cash flow to service these borrowings.